Drug showing promise in kidney cancer treatment : comparemel

LITTLE ROCK — An experimental immunotherapy in Phase 1 Clinical Trials at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has given a Little Rock

Related Keywords

Arkansas , United States , Little Rock , University Of Arkansas , Michael Birrer , Cancer Clinical Trials Team , Winthropp Rockefeller Cancer Institute , Drug Administration , Medical Sciences , Cancer Institute , Clinical Trials Unit , Clinical Trials Team , Phasei Unit , Phasei Clinical Trial , News , Ocal ,